Search Results for "Human Growth Hormone And Ptsd"

20:17 EDT 28th June 2017 | BioPortfolio

Matching Channels

Growth hormone GH

Somatropin Hgh rDNA Pfizer

What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...

EGF receptor Mab human rDNA Amgen

Luteinizing hormone LH and folliclestimulating hormone FSH

Follicle stimulating hormone FSH

Follicle-stimulating hormone (FSH) now has become an established means of ovulation induction (OI) as part of assisted reproductive technology (ART). FSH is used to induce development of multiple foll...

Matching News

What roundworms can teach us about human growth

(KU Leuven) Human beings and the roundworm C. elegans have more in common than you'd expect. Thanks to a common ancestor more than 700 million years ago humans and roundworms have a similar hormone to...

Longer-Acting Growth Hormones Promising for Adult GH Deficiency

Growth hormone derivative somapacitan and recombinant human growth hormone somavaratan both produce data suggesting weekly or even biweekly dosing is safe and effective. Medscape Medical News

Growth hormone therapy enhances recovery of patients with spinal damage

Growth hormone treatment combined with physical therapy over six months significantly improved sensory function in patients with complete spinal injuries. This research is the first human study to inv...

Growth Hormone May Be Novel Therapy for Very Rare Bone Disease

Recombinant human growth hormone (rhGH) is a potential novel therapy for fibrogenesis imperfecta ossium (FIO), a very rare but disabling and ultimately fatal bone disease, a small study from India sug...

Oxytocin Being Tested for Treatment of PTSD and Alcohol Abuse

NewsA new trial may hold new hope for military personnel through treatment with oxytocin, sometimes referred to as the “love hormone.”

Mutation of growth hormone receptor gene in men found to lengthen lifespan

(Medical Xpress)—A team of researchers with member affiliations in the U.S., France and Israel has found that a mutation in a growth hormone receptor gene can make some men live longer. In their pap...

Growth Hormone Improves Sensory Function in Complete Spinal Injury

Patients with complete dorsal spinal cord injury and growth-hormone deficiency show improvement in sensory function when treated for 6 months with the hormone, according to a proof-of-concept study. ...

Growth hormone deficiency market to expand at a steady CAGR of 3.9%

The global growth hormone deficiency (GHD) space, which covers the seven major markets of the USA, France,…

Matching PubMed Articles

Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone.

To extend available dosing options in the treatment of growth hormone deficiency, a comparative pharmacokinetic and pharmacodynamic phase-1 clinical study involving subcutaneous administration of grow...

Oral delivery of human growth hormone: Preparation, characterization, and pharmacokinetics.

Daily subcutaneous injection of human growth hormone has been used for the treatment of growth hormone deficiency and growth failure but has led to poor patient compliance and renal toxicity. Thus, it...

Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children.

MOD-4023 is a long-acting human growth hormone (hGH) in clinical trials for the treatment of growth hormone deficiency (GHD). A key goal is maintenance of serum concentrations of insulin-like growth f...

Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence.

The Pediatric Endocrine Society recently published new guidelines for the use of human growth hormone (hGH) and human insulin-like growth factor-I (hIGF-I) treatment for growth hormone deficiency, idi...

First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-I.

This study is a first time assessment of safety and tolerability, pharmacokinetics, and pharmacodynamics of RO5046013 in human, in comparison with unmodified rhIGF-I.

Search Whole site using Google

Quick Search
Advertisement Advertisement